Association of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients.
Capule F*, Tragulpiankit P, Mahasirimongkol S, Jittikoon J, Wichukchinda N, Theresa Alentajan-Aleta L, James Barit JV, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Salonga R, San Gabriel KF, Lynn Silao C. Pharmacogenomics journal 2020; 20(3): 533-541.
Knowledge, attitude, and practice towards pharmacogenomics among hospital pharmacists in Thailand
The efficacy of honey and a Thai Herbal Oil preparation in the treatment of pressure ulcers based on Thai traditional medicine wound diagnosis versus standard practice: An open-label randomized controlled trial
Dorji C, Tragulpiankit P*, Riewpaiboon A, Tobgay T. Drug Safety 2016; 39(12): 1239-1250.
2015
Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.
Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W*. Journal of Human Genetics 2015; 1-9
Evaluation of Thai and Narnajo’s Algorithm for Assessing Routine Pharmacovigilance Case Reports Using WHO-UMC Causality Assessment Criteria as Reference
Suwankesawong W, Sriphiromya P, Tragulpiankit P, Phetcharat C, Sornsrivichai V, Pokhagul P. Drug Safety 2015; 38(10): 1019-1020
Knowledge About Adverse Drug Reaction and Reporting Among the Healthcare Professionals in Bhutan
Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T. Drug Safety 2015; 38(10): 946-946
Patterns of Spontaneously Reported Adverse Drug Reaction in Bhutan
Dorji C, Tragulpiankit P, Dema N. Drug Safety 2015; 38(10): 981-981
2014
Adverse Drug Event of Hospitalized Patients from Multi-Hospitals in Thailand
Tragulpiankit P, Yeesoonpan N, Ninsananda T, Chindavijak B, Chulavatnatol S, Chaikledkaew U, Uaviseswong T. Pharmacoepidemiology and drug safety 2014; 23: 289-289
Drug Discrepancy and Medication Error of Admitted Patients by Medication Reconciliation Process
Unin J, Tragulpiankit P, Ningsananda T, Nilpetchploy R. Pharmacoepidemiology and drug safety 2014; 23: 122-123
Drug-Related Hospital Readmission in Community Hospital, Thailand
Unin J, Tragulpiankit P, Moungnoi C, Channalao P. Pharmacoepidemiology and drug safety 2014; 23: 123-123
Pharmacist Participation in the Reduction of Preventable Adverse Drug Reactions in Thai Hospitalised Patients
Tragulpiankit P, Kaojarern S, Pummangura C, Wananukul W, Luscombe DK. Journal of Applied Therapeutic Research 2009;7(1)
2008
Prevalence and characteristics of adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients at a large teaching hospital, Thailand.
Limsuwan T, Tragulpiankit P, Chulavatnatol S, Janwityanujit S, Sirikhedgon U, Somjarit S. European Journal of Dermatology 2008;18:262-3.
2007
Adverse Drug Event of Rheumatoid Arthritis and Osteoarthritis Ambulatory Patients in a Large
Tragulpiankit P, Chulavatnatol S, Limsuwan,T , Sirikhedgon U, Somjarit S Drug Safety 2007; 30(10): 950.
Development of a New Causality Assessment Method for Thai Adverse Drug Reaction Monitoring and Reporting
Suwankesawong W, Tragulpiankit P, Yothapitak J, Songsiriphun R. Drug Safety 2007; 30(10): 948..
Drug Therapy Problem Management by Pharmacist in Paediatric Intensive Care Unit at a Large Teaching Hospital, Thailand
Piebpien P, Tragulpiankit P, Preutthipan A, Montakantikul P. Drug Safety 2007; 30(10): 949
2006
Preliminary review of Thai pharmacists
Tragulpiankit P, Chulavatnatol S. Drug Saf 2006;29:976.
2005
Prevention of adverse drug reactions in hospitalised patients by pharmacist participation at a large teaching hospital in Thailand.
Tragulpiankit P, Pummangura C, Luscombe DK, Kaojarern S, Wananukul W, Montakantikul P, Nathisuwan S. Drug Safety 2005;28(10):931.
2004
Characteristics of adverse drug reactions and patient at risk in medical wards.
Pummangura C, Tragulpiankit P, Kaojarern S, Wananukul W, Montakantikul P, Luscombe DK, Pomyen N. Pharmacy World & Science 2004;26:A100.
Reducing the risk of drug-induced adverse events in hospitalized patients.